Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Blocking interferon-gamma might help treat various autoimmune diseases.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Effective symptom management in IBD improves quality of life and prevents complications.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

A new method improves the accuracy and reliability of language models by up to 42%.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

TNF-alpha inhibitors can cause various immune-related skin issues.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.